ArticleSAGE open medicine2016

An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease.

Devada Singh-Franco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.